Oestrogens and Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 15, Issue 7, 2000, Pages 600-609

  Birkhäuser, Martin H ^a   Strnad, Jindrich ^b   Kämpf, Christian ^b   Bahro, Marcel ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alzheimer's disease; Brain function; Gender differences; Hormones; Menopause; Oestrogen

Indexed keywords

ESTROGEN;

ALZHEIMER DISEASE; BRAIN FUNCTION; DISEASE ASSOCIATION; FEMALE; GENDER; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; REVIEW; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; BRAIN; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN; SEX CHARACTERISTICS; TREATMENT OUTCOME; HUMANS;

EID: 0033853766     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1166(200007)15:7<600::AID-GPS155>3.0.CO;2-7     Document Type: Review

References (103)

1. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women
2. Interactions between estrogens and catecholamines. III. Studies on the methylation of catecholestrogens, catecholamines and other catechols by the catechol-O-methyltransferases of human liver
3. Estrogen replacement therapy and cognitive functioning in older women
4. The cholinergic hypothesis of geriatric memory dysfunction
5. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease
6. The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat
7. Hydrogen peroxide mediates amyloid β-protein toxicity
8. Hormonal status affects the reactivity of the cerebral vasculature
9. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects
10. The role of estrogen deficiency in the ageing central nervous system
11. Role of estrogens in peripheral and cerebral glucose utilization
12. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
13. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease
14. Estrogen-induced alterations in synaptic morphology in the midbrain central grey
15. Effects on estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats
16. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
17. Alzheimer's disease: A disorder of cortical cholinergic innervation
18. Estrogen improves psychological function in asymptomatic postmenopausal women
19. Memory and cognitive function in man: Does the cholinergic system have a specific role?
20. Interleukin-6: A cytokine for gerontologists
21. Apolipoprotein E genotypes in patients with Alzheimer's disease: Implications for the risk of dementia among relatives
22. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type
23. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women
24. Effects of estrogen and fimbria/fornix transection on p75N0FR and expression in the medical septum and diagonal band of Broca
25. The epidemiology of dementia
26. A case-control study of Alzheimer's disease
27. The accumulation of noradrenaline and 5-hydroxytryptamine in three regions of mouse brain after tetrabenazine and iproniazid: Effects of ethinyloestradiol and progesterone
28. Variations in sex-related cognitive abilities across the menstrual cycle
29. Estrogen-related variations in human spatial and articulatory-motor skills
30. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills
31. Estrogens and dementia: A clinical and epidemiological update
32. Cognitive deficits of men and women with Alzheimer's disease
33. Spatial disorientation in Alzheimer's disease
34. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and non-demented control subjects
35. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease
36. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)
37. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: A placebo-controlled double blind study
38. Cytokines and estrogen in bone: Anti-osteoporotic effects
39. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation
40. Estrogen regulates metabolism of Alzheimer's amyloid-β precursor protein
41. Human intelligence: Sex differences
42. The prevalence of dementia: A quantitative integration of the literature
43. Estrogen use and verbal memory in healthy postmenopausal women
44. Development of dementing illnesses in an 80-year-old volunteer cohort
45. New insights into estrogen action on the brain
46. Cognitive pattern in men and women is influenced by fluctuations in sex hormones
47. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease
48. Possible short-term-memory loss associated with nafarelin acetate
49. Effects of menstrual cycle on creativity
50. Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp)
51. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats
52. Sex hormone modulation of neural development in vitro
53. Sex differences in human brain asymmetry: A clinical survey
54. Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: A basis for potential developmental interactions of estrogen with neurotrophins
55. Epidemiology of dementia in a Finnish population
56. Antioxidant properties of steroids
57. Lack of postmenopausal estrogen replacement therapy and the risk of dementia
58. Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution
59. Acute administration of high doses of estrogen increases glucose utilization throughout brain
60. Memory complaints associated with the use of gonadotropin-releasing-hormone agonists: A preliminary study
61. Estrogens as antioxidants
62. An open trial of estrogen therapy for dementia of the Alzheimer type in women
63. Low-dose estrogen replacement therapy for Alzheimer's disease in women
64. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type
65. Estrogen increases cerebral and cerebellar blood flow in post-menopausal women
66. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
67. Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task
68. Estrogen deficiency and risk of Alzheimer's disease in women
69. Estrogen replacement therapy and risk of Alzheimer's disease
70. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer's disease in women
71. Genetic susceptibility to Alzheimer's disease
72. Variations in memory function and sex steroid hormones across the menstrual cycle
73. Effects of estrogen on memory function in surgically menopausal women
74. Apolipoprotein E polymorphism and Alzheimer's disease
75. The effect of short-term estrogen replacement therapy on cognition: A randomized double-blind, cross-over trial in postmenopausal women
76. Apolipoprotein E, dementia and cortical deposition of beta-amyloid protein
77. Extrogen replacement therapy and memory in older women
78. Depression and Alzheimer's disease
79. Increased antioxidant enzyme activity in amyloid betaprotein-resistant cells
80. Central noradrenergic neurones concentrate 3H-oestradiol
81. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study
82. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
83. The effect of exogenous oestrogens on depression in menopausal women
84. Apolipoprotein E e4 allele and the lifetime risk of Alzheimer's disease
85. Sex differences in the functional organization of the brain for language
86. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
87. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women
88. Add-back estrogen reverses cognitive deficits induced by a gonadotropin-releasing-hormone agonist in women with leiomyomata uteri
89. Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus
90. Effects of estrogen changes during the menstrual-cycle on spatial performance
91. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats
92. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons
93. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
94. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
95. Novel vascular and anti-inflammatory actions of estrogen-implications for Alzheimer's disease. Oral communications
96. Organotypic culture of the developing cerebral cortex and hypothalamus: Relevance to sexual differentiation
97. Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors
98. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain
99. Gender differences in behaviour: Activating effects of cross-sex hormones
100. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
101. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat